Advertisement

About the Cover

August 31, 2017; 130 (9)

Cover image expansion

Platelets treated with selinexor retain cytoskeletal integrity (β-tubulin, green; F-actin, red), which suggests that selinexor-induced thrombocytopenia is not caused by aberrant platelet activation. See the article by Machlus et al on page 1132.